Human Combinatorial Antibody Library-based Monoclonal Antibody VAY736

Known as: HuCAL-based Antibody VAY736, VAY736 
A fully human combinatorial antibody library (HuCAL)-derived monoclonal antibody targeting the B-cell-activating factor receptor (BAFF-R), with… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
OBJECTIVES To evaluate the efficacy and safety of ianalumab (VAY736), a B cell-depleting, B cell activating factor receptor… Expand
Is this relevant?
2019
2019
Drug-resistant acute lymphoblastic leukemia (ALL) patients do not respond to standard chemotherapy, and an urgent need exists to… Expand
Is this relevant?
2018
2018
Background According to international consensus, disease activity in primary Sjogren’s syndrome (pSS) patients shall be scored… Expand
Is this relevant?
2017
2017
Background Overexpression of B cell activating factor (BAFF) contributes to the pathogenesis of primary Sjögren's syndrome (pSS… Expand
Is this relevant?
2017
2017
Background Systemic lupus erythematosus (SLE) is a chronic autoimmune disease affecting wide range of systems including the… Expand
Is this relevant?
2016
2016
Background VAY736 is a novel, defucosylated, human IgG1 mAb targeting the receptor for B cell activating Factor of the TNF family… Expand
Is this relevant?